|
2013-04-10 |
2013-04-08 |
V
Vente
|
LICHTINGER PEDRO
Former CEO
|
11 312
+43.2%
426,31
3 224 686 $US
|
11 312
+43.2%
|
426,31
|
3 224 686 $US
|
|
|
2013-04-10 |
2013-04-08 |
V
Vente
|
LICHTINGER PEDRO
Former CEO
|
31 502
-45.5%
232,67
1 553 247 $US
|
31 502
-45.5%
|
232,67
|
1 553 247 $US
|
|
|
2012-11-19 |
2012-11-08 |
A
Achat
|
LICHTINGER PEDRO
CEO and President
Dirigeant
|
42 336
-31.0%
451,54
4 910 816 $US
|
42 336
-31.0%
|
451,54
|
4 910 816 $US
|
|
|
2012-06-20 |
2012-06-11 |
V
Vente
|
CHANG JOSEPH Y
Administrateur non-exécutif
|
3 461
-3.3%
15,30
52 953 $US
|
3 461
-3.3%
|
15,30
|
52 953 $US
|
|
|
2011-08-09 |
2011-08-09 |
A
Achat
|
ALTIG ANTHONY E
Administrateur non-exécutif
|
5 000
+inf%
7,44
37 213 $US
|
5 000
+inf%
|
7,44
|
37 213 $US
|
|
|
2011-08-04 |
2011-08-04 |
A
Achat
|
LICHTINGER PEDRO
CEO and President
Administrateur exécutif
|
25 000
+38.0%
8,98
224 450 $US
|
25 000
+38.0%
|
8,98
|
224 450 $US
|
|
|
2010-05-13 |
2010-05-12 |
V
Vente
|
CHANG JOSEPH Y
Administrateur non-exécutif
|
3 461
-3.5%
11,75
40 667 $US
|
3 461
-3.5%
|
11,75
|
40 667 $US
|
|
|
2010-05-13 |
2010-05-12 |
V
Vente
|
CHANG JOSEPH Y
Administrateur non-exécutif
|
4 615
-4.6%
11,75
54 226 $US
|
4 615
-4.6%
|
11,75
|
54 226 $US
|
|
|
2009-12-29 |
2009-12-29 |
A
Achat
|
Chang Michael N
CEO and President
Administrateur exécutif
|
8 000
+3.8%
10,80
86 400 $US
|
8 000
+3.8%
|
10,80
|
86 400 $US
|
|
|
2009-12-29 |
2009-12-29 |
A
Achat
|
Che Tessie M
COO and SVP
Dirigeant
|
8 000
+3.8%
10,80
86 400 $US
|
8 000
+3.8%
|
10,80
|
86 400 $US
|
|
|
2009-12-29 |
2009-12-28 |
A
Achat
|
Chang Michael N
CEO and President
Administrateur exécutif
|
10 000
+4.9%
10,85
108 500 $US
|
10 000
+4.9%
|
10,85
|
108 500 $US
|
|
|
2009-12-29 |
2009-12-28 |
A
Achat
|
Che Tessie M
COO and SVP
Dirigeant
|
10 000
+4.9%
10,85
108 500 $US
|
10 000
+4.9%
|
10,85
|
108 500 $US
|
|
|
2009-12-02 |
2009-12-02 |
A
Achat
|
Shue Youe Kong
VP, Clinical Development
Dirigeant
|
500
+0.6%
10,89
5 445 $US
|
500
+0.6%
|
10,89
|
5 445 $US
|
|
|
2009-12-02 |
2009-12-02 |
A
Achat
|
Shue Youe Kong
VP, Clinical Development
Dirigeant
|
500
+0.6%
10,90
5 450 $US
|
500
+0.6%
|
10,90
|
5 450 $US
|
|
|
2009-12-02 |
2009-12-02 |
A
Achat
|
Shue Youe Kong
VP, Clinical Development
Dirigeant
|
1 000
+1.2%
10,96
10 960 $US
|
1 000
+1.2%
|
10,96
|
10 960 $US
|
|
|
2009-12-02 |
2009-12-01 |
A
Achat
|
Shue Youe Kong
VP, Clinical Development
Dirigeant
|
1 000
+1.3%
11,10
11 100 $US
|
1 000
+1.3%
|
11,10
|
11 100 $US
|
|
|
2009-11-25 |
2009-11-25 |
A
Achat
|
Che Tessie M
COO and SVP
Dirigeant
|
7 000
+3.6%
11,50
80 500 $US
|
7 000
+3.6%
|
11,50
|
80 500 $US
|
|
|
2009-11-25 |
2009-11-25 |
A
Achat
|
Chang Michael N
CEO and President
Administrateur exécutif
|
7 000
+3.6%
11,50
80 500 $US
|
7 000
+3.6%
|
11,50
|
80 500 $US
|
|
|
2009-11-25 |
2009-11-25 |
A
Achat
|
Che Tessie M
COO and SVP
Dirigeant
|
8 000
+4.3%
11,53
92 240 $US
|
8 000
+4.3%
|
11,53
|
92 240 $US
|
|
|
2009-11-25 |
2009-11-25 |
A
Achat
|
Chang Michael N
CEO and President
Administrateur exécutif
|
8 000
+4.3%
11,53
92 240 $US
|
8 000
+4.3%
|
11,53
|
92 240 $US
|
|
|
2008-07-22 |
2008-07-18 |
A
Achat
|
SCHREIBER ALAIN
Administrateur non-exécutif
|
628 931
+inf%
8,48
5 333 335 $US
|
628 931
+inf%
|
8,48
|
5 333 335 $US
|
|
|
2008-07-22 |
2008-07-18 |
A
Achat
|
SCHREIBER ALAIN
Administrateur non-exécutif
|
314 465
+inf%
8,48
2 666 663 $US
|
314 465
+inf%
|
8,48
|
2 666 663 $US
|
|
|
2008-07-25 |
2008-07-02 |
V
Vente
|
EDELMAN JOSEPH
Actionnaire important
|
8 000
-6.6%
7,40
59 200 $US
|
8 000
-6.6%
|
7,40
|
59 200 $US
|
|
|
2008-07-25 |
2008-07-02 |
V
Vente
|
EDELMAN JOSEPH
Actionnaire important
|
192 000
-7.0%
7,40
1 420 800 $US
|
192 000
-7.0%
|
7,40
|
1 420 800 $US
|
|
|
2008-06-17 |
2008-06-13 |
A
Achat
|
Chang Michael N
CEO and President
Administrateur exécutif
|
5 000
+3.0%
7,00
35 000 $US
|
5 000
+3.0%
|
7,00
|
35 000 $US
|
|
|
2008-06-17 |
2008-06-13 |
A
Achat
|
Che Tessie M
COO and SVP
Dirigeant
|
5 000
+3.0%
7,00
35 000 $US
|
5 000
+3.0%
|
7,00
|
35 000 $US
|
|
|
2008-05-16 |
2008-05-15 |
AP
Achat planifié
|
Che Tessie M
COO & SVP
Dirigeant
|
2 500
+1.5%
6,04
15 088 $US
|
2 500
+1.5%
|
6,04
|
15 088 $US
|
|
|
2008-05-16 |
2008-05-15 |
AP
Achat planifié
|
Chang Michael N
CEO & President
Administrateur exécutif
|
2 042
+0.8%
6,04
12 323 $US
|
2 042
+0.8%
|
6,04
|
12 323 $US
|
|
|
2007-12-27 |
2007-12-19 |
V
Vente
|
EDELMAN JOSEPH
Actionnaire important
|
12 220
-0.4%
7,75
94 683 $US
|
12 220
-0.4%
|
7,75
|
94 683 $US
|
|
|
2007-12-27 |
2007-12-18 |
V
Vente
|
EDELMAN JOSEPH
Actionnaire important
|
1 464
-1.2%
7,71
11 292 $US
|
1 464
-1.2%
|
7,71
|
11 292 $US
|
|
|
2007-12-27 |
2007-12-18 |
V
Vente
|
EDELMAN JOSEPH
Actionnaire important
|
22 936
-0.8%
7,71
176 905 $US
|
22 936
-0.8%
|
7,71
|
176 905 $US
|
|
|
2007-12-27 |
2007-12-17 |
V
Vente
|
EDELMAN JOSEPH
Actionnaire important
|
756
-0.6%
7,71
5 829 $US
|
756
-0.6%
|
7,71
|
5 829 $US
|
|
|
2007-12-27 |
2007-12-17 |
V
Vente
|
EDELMAN JOSEPH
Actionnaire important
|
11 844
-0.4%
7,71
91 321 $US
|
11 844
-0.4%
|
7,71
|
91 321 $US
|
|
|
2007-12-27 |
2007-12-13 |
V
Vente
|
EDELMAN JOSEPH
Actionnaire important
|
780
-0.6%
7,75
6 044 $US
|
780
-0.6%
|
7,75
|
6 044 $US
|
|
|
2007-12-27 |
2007-12-13 |
V
Vente
|
EDELMAN JOSEPH
Actionnaire important
|
348
-0.3%
7,38
2 569 $US
|
348
-0.3%
|
7,38
|
2 569 $US
|
|
|
2007-12-27 |
2007-12-13 |
V
Vente
|
EDELMAN JOSEPH
Actionnaire important
|
5 452
-0.2%
7,38
40 245 $US
|
5 452
-0.2%
|
7,38
|
40 245 $US
|
|
|
2007-11-19 |
2007-11-15 |
A
Achat
|
Chang Michael N
CEO
Administrateur exécutif
|
1 000
+0.4%
5,95
5 950 $US
|
1 000
+0.4%
|
5,95
|
5 950 $US
|
|
|
2007-11-19 |
2007-11-15 |
AP
Achat planifié
|
Che Tessie M
COO
Dirigeant
|
1 000
+0.6%
5,95
5 950 $US
|
1 000
+0.6%
|
5,95
|
5 950 $US
|
|
|
2007-11-19 |
2007-11-15 |
A
Achat
|
Chang Michael N
CEO
Administrateur exécutif
|
1 000
+0.6%
5,95
5 950 $US
|
1 000
+0.6%
|
5,95
|
5 950 $US
|
|
|
2007-11-19 |
2007-11-15 |
AP
Achat planifié
|
Poulos Kevin P
Chief Commercial Officer
Dirigeant
|
1 000
+166.7%
5,95
5 950 $US
|
1 000
+166.7%
|
5,95
|
5 950 $US
|
|
|
2007-11-19 |
2007-11-15 |
AP
Achat planifié
|
Che Tessie M
COO
Dirigeant
|
1 000
+0.4%
5,95
5 950 $US
|
1 000
+0.4%
|
5,95
|
5 950 $US
|
|
|
2007-11-19 |
2007-11-15 |
AP
Achat planifié
|
Prunty John D
CFO
Dirigeant
|
1 000
+inf%
5,95
5 950 $US
|
1 000
+inf%
|
5,95
|
5 950 $US
|
|
|
2007-11-19 |
2007-11-15 |
AP
Achat planifié
|
Shue Youe Kong
VP Clinical Development
Dirigeant
|
1 000
+1.3%
5,95
5 950 $US
|
1 000
+1.3%
|
5,95
|
5 950 $US
|
|
|
2007-08-13 |
2007-08-10 |
A
Achat
|
Shue Youe Kong
VP Clinical Development
Dirigeant
|
300
+0.4%
8,24
2 472 $US
|
300
+0.4%
|
8,24
|
2 472 $US
|
|
|
2007-08-13 |
2007-08-10 |
A
Achat
|
Shue Youe Kong
VP Clinical Development
Dirigeant
|
200
+0.3%
8,27
1 654 $US
|
200
+0.3%
|
8,27
|
1 654 $US
|
|
|
2007-08-13 |
2007-08-10 |
A
Achat
|
Shue Youe Kong
VP Clinical Development
Dirigeant
|
100
+0.1%
8,28
828 $US
|
100
+0.1%
|
8,28
|
828 $US
|
|
|
2007-08-13 |
2007-08-10 |
A
Achat
|
Shue Youe Kong
VP Clinical Development
Dirigeant
|
200
+0.3%
8,29
1 658 $US
|
200
+0.3%
|
8,29
|
1 658 $US
|
|
|
2007-08-13 |
2007-08-10 |
A
Achat
|
Shue Youe Kong
VP Clinical Development
Dirigeant
|
1 200
+1.7%
8,30
9 960 $US
|
1 200
+1.7%
|
8,30
|
9 960 $US
|
|
|
2007-08-13 |
2007-08-09 |
A
Achat
|
Shue Youe Kong
VP Clinical Development
Dirigeant
|
500
+0.7%
8,30
4 150 $US
|
500
+0.7%
|
8,30
|
4 150 $US
|
|
|
2007-08-10 |
2007-08-09 |
A
Achat
|
Chang Michael N
President & CEO
Administrateur exécutif
|
30 000
+21.5%
8,20
246 000 $US
|
30 000
+21.5%
|
8,20
|
246 000 $US
|
|
|
2007-08-10 |
2007-08-09 |
A
Achat
|
Che Tessie M
Senior VP & COO
Dirigeant
|
30 000
+21.5%
8,20
246 000 $US
|
30 000
+21.5%
|
8,20
|
246 000 $US
|
|
|
2007-08-08 |
2007-08-06 |
A
Achat
|
Che Tessie M
Senior VP & COO
Dirigeant
|
10 000
+7.7%
9,05
90 500 $US
|
10 000
+7.7%
|
9,05
|
90 500 $US
|
|
|
2007-08-08 |
2007-08-06 |
A
Achat
|
Chang Michael N
President and CEO
Administrateur exécutif
|
10 000
+7.7%
9,05
90 500 $US
|
10 000
+7.7%
|
9,05
|
90 500 $US
|
|
|
2007-08-08 |
2007-07-16 |
A
Achat
|
Che Tessie M
Senior VP & COO
Dirigeant
|
5 000
+4.0%
9,80
49 000 $US
|
5 000
+4.0%
|
9,80
|
49 000 $US
|
|
|
2007-08-08 |
2007-07-16 |
A
Achat
|
Che Tessie M
Senior VP & COO
Dirigeant
|
5 000
+4.2%
9,92
49 600 $US
|
5 000
+4.2%
|
9,92
|
49 600 $US
|
|
|
2007-07-18 |
2007-07-16 |
A
Achat
|
Chang Michael N
President, CEO
Administrateur exécutif
|
5 000
+4.0%
9,80
49 000 $US
|
5 000
+4.0%
|
9,80
|
49 000 $US
|
|
|
2007-07-18 |
2007-07-16 |
A
Achat
|
Chang Michael N
President, CEO
Administrateur exécutif
|
5 000
+4.2%
9,92
49 600 $US
|
5 000
+4.2%
|
9,92
|
49 600 $US
|
|
|
2007-02-23 |
2007-02-21 |
V
Vente
|
Par Pharmacuetical, Inc.
Actionnaire important
|
1 050 000
-45.5%
7,00
7 350 000 $US
|
1 050 000
-45.5%
|
7,00
|
7 350 000 $US
|
|
|
2007-02-14 |
2007-02-14 |
A
Achat
|
Chang Michael N
President, CEO
Administrateur exécutif
|
114 965
+2491.1%
7,00
804 755 $US
|
114 965
+2491.1%
|
7,00
|
804 755 $US
|
|
|
2007-02-14 |
2007-02-14 |
A
Achat
|
Poulos Kevin P
VP, Marketing and Sales
Dirigeant
|
600
+inf%
7,00
4 200 $US
|
600
+inf%
|
7,00
|
4 200 $US
|
|